Bacillus calmette-guerin substrain danish 1331 live antigen clinical trials
Also written BCG-Denmark 1331 (Statens Serum Institute).
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2003
How each study uses bacillus calmette-guerin substrain danish 1331 live antigen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2014 | 2 |
| 2015 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
University of Oxford (3) · Bandim Health Project (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses bacillus calmette-guerin substrain danish 1331 live antigen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised TrialTerminatedPhase 4Bandim Health ProjectNCT02504203Written as BCG-Denmark 1331 (Statens Serum Institute)
- Trial of Two Strains of BCGCompletedPhase 4Bandim Health ProjectNCT02447536Written as BCG-Denmark 1331 (Statens Serum Institute)
- Heterologous Effects of BCG in Healthy UK AdultsCompletedNot applicableUniversity of OxfordNCT02380508Written as BCG SSI
- A Clinical Challenge Study of BCG in Healthy VolunteersCompletedNot applicableUniversity of OxfordNCT02088892Written as BCG SSI
- A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy VolunteersCompletedNot applicableUniversity of OxfordNCT00480714Written as BCG (SSI Strain)
Given beside what is tested · 1 — bacillus calmette-guerin substrain danish 1331 live antigen is usual care or a partner of the new treatment
Codes
What other systems call bacillus calmette-guerin substrain danish 1331 live antigen · ClinicalTrials.gg INT014848
- UNII (FDA) 4CGF0IDN3WBACILLUS CALMETTE-GUERIN SUBSTRAIN DANISH 1331 LIVE ANTIGENOne source FDA
- NCI Thesaurus C180987Bacillus Calmette-Guerin Substrain Danish 1331 Live AntigenOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 4CGF0IDN3W | BACILLUS CALMETTE-GUERIN SUBSTRAIN DANISH 1331 LIVE ANTIGEN | One source FDA |
| NCI Thesaurus | C180987 | Bacillus Calmette-Guerin Substrain Danish 1331 Live Antigen | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.